Global Tumor Immune Cell Therapy Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Cancer immune cell therapy is a treatment method that activates the function of the patient's own immune cells, thereby enhancing the immune cells' ability to attack cancer and inhibit cancer cells. In actual treatment, we extract immune cells involved in attacking cancer from the patient's blood, cancer tissue, ascites, and pleural effusion, proliferate, activate, and enhance their functions in vitro before returning them to the patient.
The global Tumor Immune Cell Therapy market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Tumor Immune Cell Therapy Industry Forecast” looks at past sales and reviews total world Tumor Immune Cell Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Tumor Immune Cell Therapy sales for 2023 through 2029. With Tumor Immune Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor Immune Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global Tumor Immune Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tumor Immune Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tumor Immune Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor Immune Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor Immune Cell Therapy.
United States market for Tumor Immune Cell Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Tumor Immune Cell Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Tumor Immune Cell Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Tumor Immune Cell Therapy players cover MEDINET Co, Erytech, Seta Clinic Group, Takeda, SBI Holdings, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Immune Cell Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Cancer immune cell therapy is a treatment method that activates the function of the patient's own immune cells, thereby enhancing the immune cells' ability to attack cancer and inhibit cancer cells. In actual treatment, we extract immune cells involved in attacking cancer from the patient's blood, cancer tissue, ascites, and pleural effusion, proliferate, activate, and enhance their functions in vitro before returning them to the patient.
The global Tumor Immune Cell Therapy market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Tumor Immune Cell Therapy Industry Forecast” looks at past sales and reviews total world Tumor Immune Cell Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Tumor Immune Cell Therapy sales for 2023 through 2029. With Tumor Immune Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor Immune Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global Tumor Immune Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tumor Immune Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tumor Immune Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor Immune Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor Immune Cell Therapy.
United States market for Tumor Immune Cell Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Tumor Immune Cell Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Tumor Immune Cell Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Tumor Immune Cell Therapy players cover MEDINET Co, Erytech, Seta Clinic Group, Takeda, SBI Holdings, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Immune Cell Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Immune Checkpoint Inhibitors
- Chimeric Antigen Receptor T-cell Therapy
- Tumor-Infiltrating Lymphocytes Therapy
- Cancer Vaccines
- Bispecific Antibodies
- Cytokine Therapy
- Hematological Tumors
- Solid Tumors
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Immune Checkpoint Inhibitors
- Chimeric Antigen Receptor T-cell Therapy
- Tumor-Infiltrating Lymphocytes Therapy
- Cancer Vaccines
- Bispecific Antibodies
- Cytokine Therapy
- Hematological Tumors
- Solid Tumors
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- MEDINET Co
- Erytech
- Seta Clinic Group
- Takeda
- SBI Holdings
- Oxford BioTherapeutics
- Fate Therapeutics
- Gilead Sciences
- Novartis
- Osiris
- Vericel Corporation
- Fujifilm Cellular Dynamics
- JCR Pharmaceuticals
- Beike Biotechnology
- Golden Meditech
- Guanhao Biotech
- Beroni Group
- Legend Biotech
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tumor Immune Cell Therapy Market Size 2019-2030
2.1.2 Tumor Immune Cell Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Tumor Immune Cell Therapy by Country/Region, 2019, 2023 & 2030
2.2 Tumor Immune Cell Therapy Segment by Type
2.2.1 Immune Checkpoint Inhibitors
2.2.2 Chimeric Antigen Receptor T-cell Therapy
2.2.3 Tumor-Infiltrating Lymphocytes Therapy
2.2.4 Cancer Vaccines
2.2.5 Bispecific Antibodies
2.2.6 Cytokine Therapy
2.3 Tumor Immune Cell Therapy Market Size by Type
2.3.1 Tumor Immune Cell Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Tumor Immune Cell Therapy Market Size Market Share by Type (2019-2024)
2.4 Tumor Immune Cell Therapy Segment by Application
2.4.1 Hematological Tumors
2.4.2 Solid Tumors
2.5 Tumor Immune Cell Therapy Market Size by Application
2.5.1 Tumor Immune Cell Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Tumor Immune Cell Therapy Market Size Market Share by Application (2019-2024)
3 TUMOR IMMUNE CELL THERAPY MARKET SIZE BY PLAYER
3.1 Tumor Immune Cell Therapy Market Size Market Share by Player
3.1.1 Global Tumor Immune Cell Therapy Revenue by Player (2019-2024)
3.1.2 Global Tumor Immune Cell Therapy Revenue Market Share by Player (2019-2024)
3.2 Global Tumor Immune Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TUMOR IMMUNE CELL THERAPY BY REGION
4.1 Tumor Immune Cell Therapy Market Size by Region (2019-2024)
4.2 Global Tumor Immune Cell Therapy Annual Revenue by Country/Region (2019-2024)
4.3 Americas Tumor Immune Cell Therapy Market Size Growth (2019-2024)
4.4 APAC Tumor Immune Cell Therapy Market Size Growth (2019-2024)
4.5 Europe Tumor Immune Cell Therapy Market Size Growth (2019-2024)
4.6 Middle East & Africa Tumor Immune Cell Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Tumor Immune Cell Therapy Market Size by Country (2019-2024)
5.2 Americas Tumor Immune Cell Therapy Market Size by Type (2019-2024)
5.3 Americas Tumor Immune Cell Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor Immune Cell Therapy Market Size by Region (2019-2024)
6.2 APAC Tumor Immune Cell Therapy Market Size by Type (2019-2024)
6.3 APAC Tumor Immune Cell Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tumor Immune Cell Therapy Market Size by Country (2019-2024)
7.2 Europe Tumor Immune Cell Therapy Market Size by Type (2019-2024)
7.3 Europe Tumor Immune Cell Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tumor Immune Cell Therapy by Region (2019-2024)
8.2 Middle East & Africa Tumor Immune Cell Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Tumor Immune Cell Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TUMOR IMMUNE CELL THERAPY MARKET FORECAST
10.1 Global Tumor Immune Cell Therapy Forecast by Region (2025-2030)
10.1.1 Global Tumor Immune Cell Therapy Forecast by Region (2025-2030)
10.1.2 Americas Tumor Immune Cell Therapy Forecast
10.1.3 APAC Tumor Immune Cell Therapy Forecast
10.1.4 Europe Tumor Immune Cell Therapy Forecast
10.1.5 Middle East & Africa Tumor Immune Cell Therapy Forecast
10.2 Americas Tumor Immune Cell Therapy Forecast by Country (2025-2030)
10.2.1 United States Market Tumor Immune Cell Therapy Forecast
10.2.2 Canada Market Tumor Immune Cell Therapy Forecast
10.2.3 Mexico Market Tumor Immune Cell Therapy Forecast
10.2.4 Brazil Market Tumor Immune Cell Therapy Forecast
10.3 APAC Tumor Immune Cell Therapy Forecast by Region (2025-2030)
10.3.1 China Tumor Immune Cell Therapy Market Forecast
10.3.2 Japan Market Tumor Immune Cell Therapy Forecast
10.3.3 Korea Market Tumor Immune Cell Therapy Forecast
10.3.4 Southeast Asia Market Tumor Immune Cell Therapy Forecast
10.3.5 India Market Tumor Immune Cell Therapy Forecast
10.3.6 Australia Market Tumor Immune Cell Therapy Forecast
10.4 Europe Tumor Immune Cell Therapy Forecast by Country (2025-2030)
10.4.1 Germany Market Tumor Immune Cell Therapy Forecast
10.4.2 France Market Tumor Immune Cell Therapy Forecast
10.4.3 UK Market Tumor Immune Cell Therapy Forecast
10.4.4 Italy Market Tumor Immune Cell Therapy Forecast
10.4.5 Russia Market Tumor Immune Cell Therapy Forecast
10.5 Middle East & Africa Tumor Immune Cell Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Market Tumor Immune Cell Therapy Forecast
10.5.2 South Africa Market Tumor Immune Cell Therapy Forecast
10.5.3 Israel Market Tumor Immune Cell Therapy Forecast
10.5.4 Turkey Market Tumor Immune Cell Therapy Forecast
10.6 Global Tumor Immune Cell Therapy Forecast by Type (2025-2030)
10.7 Global Tumor Immune Cell Therapy Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Tumor Immune Cell Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 MEDINET Co
11.1.1 MEDINET Co Company Information
11.1.2 MEDINET Co Tumor Immune Cell Therapy Product Offered
11.1.3 MEDINET Co Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 MEDINET Co Main Business Overview
11.1.5 MEDINET Co Latest Developments
11.2 Erytech
11.2.1 Erytech Company Information
11.2.2 Erytech Tumor Immune Cell Therapy Product Offered
11.2.3 Erytech Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Erytech Main Business Overview
11.2.5 Erytech Latest Developments
11.3 Seta Clinic Group
11.3.1 Seta Clinic Group Company Information
11.3.2 Seta Clinic Group Tumor Immune Cell Therapy Product Offered
11.3.3 Seta Clinic Group Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Seta Clinic Group Main Business Overview
11.3.5 Seta Clinic Group Latest Developments
11.4 Takeda
11.4.1 Takeda Company Information
11.4.2 Takeda Tumor Immune Cell Therapy Product Offered
11.4.3 Takeda Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Takeda Main Business Overview
11.4.5 Takeda Latest Developments
11.5 SBI Holdings
11.5.1 SBI Holdings Company Information
11.5.2 SBI Holdings Tumor Immune Cell Therapy Product Offered
11.5.3 SBI Holdings Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 SBI Holdings Main Business Overview
11.5.5 SBI Holdings Latest Developments
11.6 Oxford BioTherapeutics
11.6.1 Oxford BioTherapeutics Company Information
11.6.2 Oxford BioTherapeutics Tumor Immune Cell Therapy Product Offered
11.6.3 Oxford BioTherapeutics Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Oxford BioTherapeutics Main Business Overview
11.6.5 Oxford BioTherapeutics Latest Developments
11.7 Fate Therapeutics
11.7.1 Fate Therapeutics Company Information
11.7.2 Fate Therapeutics Tumor Immune Cell Therapy Product Offered
11.7.3 Fate Therapeutics Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Fate Therapeutics Main Business Overview
11.7.5 Fate Therapeutics Latest Developments
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Information
11.8.2 Gilead Sciences Tumor Immune Cell Therapy Product Offered
11.8.3 Gilead Sciences Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Gilead Sciences Main Business Overview
11.8.5 Gilead Sciences Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Tumor Immune Cell Therapy Product Offered
11.9.3 Novartis Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Osiris
11.10.1 Osiris Company Information
11.10.2 Osiris Tumor Immune Cell Therapy Product Offered
11.10.3 Osiris Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Osiris Main Business Overview
11.10.5 Osiris Latest Developments
11.11 Vericel Corporation
11.11.1 Vericel Corporation Company Information
11.11.2 Vericel Corporation Tumor Immune Cell Therapy Product Offered
11.11.3 Vericel Corporation Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Vericel Corporation Main Business Overview
11.11.5 Vericel Corporation Latest Developments
11.12 Fujifilm Cellular Dynamics
11.12.1 Fujifilm Cellular Dynamics Company Information
11.12.2 Fujifilm Cellular Dynamics Tumor Immune Cell Therapy Product Offered
11.12.3 Fujifilm Cellular Dynamics Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Fujifilm Cellular Dynamics Main Business Overview
11.12.5 Fujifilm Cellular Dynamics Latest Developments
11.13 JCR Pharmaceuticals
11.13.1 JCR Pharmaceuticals Company Information
11.13.2 JCR Pharmaceuticals Tumor Immune Cell Therapy Product Offered
11.13.3 JCR Pharmaceuticals Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 JCR Pharmaceuticals Main Business Overview
11.13.5 JCR Pharmaceuticals Latest Developments
11.14 Beike Biotechnology
11.14.1 Beike Biotechnology Company Information
11.14.2 Beike Biotechnology Tumor Immune Cell Therapy Product Offered
11.14.3 Beike Biotechnology Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Beike Biotechnology Main Business Overview
11.14.5 Beike Biotechnology Latest Developments
11.15 Golden Meditech
11.15.1 Golden Meditech Company Information
11.15.2 Golden Meditech Tumor Immune Cell Therapy Product Offered
11.15.3 Golden Meditech Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Golden Meditech Main Business Overview
11.15.5 Golden Meditech Latest Developments
11.16 Guanhao Biotech
11.16.1 Guanhao Biotech Company Information
11.16.2 Guanhao Biotech Tumor Immune Cell Therapy Product Offered
11.16.3 Guanhao Biotech Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Guanhao Biotech Main Business Overview
11.16.5 Guanhao Biotech Latest Developments
11.17 Beroni Group
11.17.1 Beroni Group Company Information
11.17.2 Beroni Group Tumor Immune Cell Therapy Product Offered
11.17.3 Beroni Group Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Beroni Group Main Business Overview
11.17.5 Beroni Group Latest Developments
11.18 Legend Biotech
11.18.1 Legend Biotech Company Information
11.18.2 Legend Biotech Tumor Immune Cell Therapy Product Offered
11.18.3 Legend Biotech Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Legend Biotech Main Business Overview
11.18.5 Legend Biotech Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tumor Immune Cell Therapy Market Size 2019-2030
2.1.2 Tumor Immune Cell Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Tumor Immune Cell Therapy by Country/Region, 2019, 2023 & 2030
2.2 Tumor Immune Cell Therapy Segment by Type
2.2.1 Immune Checkpoint Inhibitors
2.2.2 Chimeric Antigen Receptor T-cell Therapy
2.2.3 Tumor-Infiltrating Lymphocytes Therapy
2.2.4 Cancer Vaccines
2.2.5 Bispecific Antibodies
2.2.6 Cytokine Therapy
2.3 Tumor Immune Cell Therapy Market Size by Type
2.3.1 Tumor Immune Cell Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Tumor Immune Cell Therapy Market Size Market Share by Type (2019-2024)
2.4 Tumor Immune Cell Therapy Segment by Application
2.4.1 Hematological Tumors
2.4.2 Solid Tumors
2.5 Tumor Immune Cell Therapy Market Size by Application
2.5.1 Tumor Immune Cell Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Tumor Immune Cell Therapy Market Size Market Share by Application (2019-2024)
3 TUMOR IMMUNE CELL THERAPY MARKET SIZE BY PLAYER
3.1 Tumor Immune Cell Therapy Market Size Market Share by Player
3.1.1 Global Tumor Immune Cell Therapy Revenue by Player (2019-2024)
3.1.2 Global Tumor Immune Cell Therapy Revenue Market Share by Player (2019-2024)
3.2 Global Tumor Immune Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TUMOR IMMUNE CELL THERAPY BY REGION
4.1 Tumor Immune Cell Therapy Market Size by Region (2019-2024)
4.2 Global Tumor Immune Cell Therapy Annual Revenue by Country/Region (2019-2024)
4.3 Americas Tumor Immune Cell Therapy Market Size Growth (2019-2024)
4.4 APAC Tumor Immune Cell Therapy Market Size Growth (2019-2024)
4.5 Europe Tumor Immune Cell Therapy Market Size Growth (2019-2024)
4.6 Middle East & Africa Tumor Immune Cell Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Tumor Immune Cell Therapy Market Size by Country (2019-2024)
5.2 Americas Tumor Immune Cell Therapy Market Size by Type (2019-2024)
5.3 Americas Tumor Immune Cell Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor Immune Cell Therapy Market Size by Region (2019-2024)
6.2 APAC Tumor Immune Cell Therapy Market Size by Type (2019-2024)
6.3 APAC Tumor Immune Cell Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tumor Immune Cell Therapy Market Size by Country (2019-2024)
7.2 Europe Tumor Immune Cell Therapy Market Size by Type (2019-2024)
7.3 Europe Tumor Immune Cell Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tumor Immune Cell Therapy by Region (2019-2024)
8.2 Middle East & Africa Tumor Immune Cell Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Tumor Immune Cell Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TUMOR IMMUNE CELL THERAPY MARKET FORECAST
10.1 Global Tumor Immune Cell Therapy Forecast by Region (2025-2030)
10.1.1 Global Tumor Immune Cell Therapy Forecast by Region (2025-2030)
10.1.2 Americas Tumor Immune Cell Therapy Forecast
10.1.3 APAC Tumor Immune Cell Therapy Forecast
10.1.4 Europe Tumor Immune Cell Therapy Forecast
10.1.5 Middle East & Africa Tumor Immune Cell Therapy Forecast
10.2 Americas Tumor Immune Cell Therapy Forecast by Country (2025-2030)
10.2.1 United States Market Tumor Immune Cell Therapy Forecast
10.2.2 Canada Market Tumor Immune Cell Therapy Forecast
10.2.3 Mexico Market Tumor Immune Cell Therapy Forecast
10.2.4 Brazil Market Tumor Immune Cell Therapy Forecast
10.3 APAC Tumor Immune Cell Therapy Forecast by Region (2025-2030)
10.3.1 China Tumor Immune Cell Therapy Market Forecast
10.3.2 Japan Market Tumor Immune Cell Therapy Forecast
10.3.3 Korea Market Tumor Immune Cell Therapy Forecast
10.3.4 Southeast Asia Market Tumor Immune Cell Therapy Forecast
10.3.5 India Market Tumor Immune Cell Therapy Forecast
10.3.6 Australia Market Tumor Immune Cell Therapy Forecast
10.4 Europe Tumor Immune Cell Therapy Forecast by Country (2025-2030)
10.4.1 Germany Market Tumor Immune Cell Therapy Forecast
10.4.2 France Market Tumor Immune Cell Therapy Forecast
10.4.3 UK Market Tumor Immune Cell Therapy Forecast
10.4.4 Italy Market Tumor Immune Cell Therapy Forecast
10.4.5 Russia Market Tumor Immune Cell Therapy Forecast
10.5 Middle East & Africa Tumor Immune Cell Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Market Tumor Immune Cell Therapy Forecast
10.5.2 South Africa Market Tumor Immune Cell Therapy Forecast
10.5.3 Israel Market Tumor Immune Cell Therapy Forecast
10.5.4 Turkey Market Tumor Immune Cell Therapy Forecast
10.6 Global Tumor Immune Cell Therapy Forecast by Type (2025-2030)
10.7 Global Tumor Immune Cell Therapy Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Tumor Immune Cell Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 MEDINET Co
11.1.1 MEDINET Co Company Information
11.1.2 MEDINET Co Tumor Immune Cell Therapy Product Offered
11.1.3 MEDINET Co Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 MEDINET Co Main Business Overview
11.1.5 MEDINET Co Latest Developments
11.2 Erytech
11.2.1 Erytech Company Information
11.2.2 Erytech Tumor Immune Cell Therapy Product Offered
11.2.3 Erytech Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Erytech Main Business Overview
11.2.5 Erytech Latest Developments
11.3 Seta Clinic Group
11.3.1 Seta Clinic Group Company Information
11.3.2 Seta Clinic Group Tumor Immune Cell Therapy Product Offered
11.3.3 Seta Clinic Group Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Seta Clinic Group Main Business Overview
11.3.5 Seta Clinic Group Latest Developments
11.4 Takeda
11.4.1 Takeda Company Information
11.4.2 Takeda Tumor Immune Cell Therapy Product Offered
11.4.3 Takeda Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Takeda Main Business Overview
11.4.5 Takeda Latest Developments
11.5 SBI Holdings
11.5.1 SBI Holdings Company Information
11.5.2 SBI Holdings Tumor Immune Cell Therapy Product Offered
11.5.3 SBI Holdings Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 SBI Holdings Main Business Overview
11.5.5 SBI Holdings Latest Developments
11.6 Oxford BioTherapeutics
11.6.1 Oxford BioTherapeutics Company Information
11.6.2 Oxford BioTherapeutics Tumor Immune Cell Therapy Product Offered
11.6.3 Oxford BioTherapeutics Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Oxford BioTherapeutics Main Business Overview
11.6.5 Oxford BioTherapeutics Latest Developments
11.7 Fate Therapeutics
11.7.1 Fate Therapeutics Company Information
11.7.2 Fate Therapeutics Tumor Immune Cell Therapy Product Offered
11.7.3 Fate Therapeutics Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Fate Therapeutics Main Business Overview
11.7.5 Fate Therapeutics Latest Developments
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Information
11.8.2 Gilead Sciences Tumor Immune Cell Therapy Product Offered
11.8.3 Gilead Sciences Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Gilead Sciences Main Business Overview
11.8.5 Gilead Sciences Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Tumor Immune Cell Therapy Product Offered
11.9.3 Novartis Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Osiris
11.10.1 Osiris Company Information
11.10.2 Osiris Tumor Immune Cell Therapy Product Offered
11.10.3 Osiris Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Osiris Main Business Overview
11.10.5 Osiris Latest Developments
11.11 Vericel Corporation
11.11.1 Vericel Corporation Company Information
11.11.2 Vericel Corporation Tumor Immune Cell Therapy Product Offered
11.11.3 Vericel Corporation Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Vericel Corporation Main Business Overview
11.11.5 Vericel Corporation Latest Developments
11.12 Fujifilm Cellular Dynamics
11.12.1 Fujifilm Cellular Dynamics Company Information
11.12.2 Fujifilm Cellular Dynamics Tumor Immune Cell Therapy Product Offered
11.12.3 Fujifilm Cellular Dynamics Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Fujifilm Cellular Dynamics Main Business Overview
11.12.5 Fujifilm Cellular Dynamics Latest Developments
11.13 JCR Pharmaceuticals
11.13.1 JCR Pharmaceuticals Company Information
11.13.2 JCR Pharmaceuticals Tumor Immune Cell Therapy Product Offered
11.13.3 JCR Pharmaceuticals Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 JCR Pharmaceuticals Main Business Overview
11.13.5 JCR Pharmaceuticals Latest Developments
11.14 Beike Biotechnology
11.14.1 Beike Biotechnology Company Information
11.14.2 Beike Biotechnology Tumor Immune Cell Therapy Product Offered
11.14.3 Beike Biotechnology Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Beike Biotechnology Main Business Overview
11.14.5 Beike Biotechnology Latest Developments
11.15 Golden Meditech
11.15.1 Golden Meditech Company Information
11.15.2 Golden Meditech Tumor Immune Cell Therapy Product Offered
11.15.3 Golden Meditech Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Golden Meditech Main Business Overview
11.15.5 Golden Meditech Latest Developments
11.16 Guanhao Biotech
11.16.1 Guanhao Biotech Company Information
11.16.2 Guanhao Biotech Tumor Immune Cell Therapy Product Offered
11.16.3 Guanhao Biotech Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Guanhao Biotech Main Business Overview
11.16.5 Guanhao Biotech Latest Developments
11.17 Beroni Group
11.17.1 Beroni Group Company Information
11.17.2 Beroni Group Tumor Immune Cell Therapy Product Offered
11.17.3 Beroni Group Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Beroni Group Main Business Overview
11.17.5 Beroni Group Latest Developments
11.18 Legend Biotech
11.18.1 Legend Biotech Company Information
11.18.2 Legend Biotech Tumor Immune Cell Therapy Product Offered
11.18.3 Legend Biotech Tumor Immune Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Legend Biotech Main Business Overview
11.18.5 Legend Biotech Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tumor Immune Cell Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Tumor Immune Cell Therapy Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Immune Checkpoint Inhibitors
Table 4. Major Players of Chimeric Antigen Receptor T-cell Therapy
Table 5. Major Players of Tumor-Infiltrating Lymphocytes Therapy
Table 6. Major Players of Cancer Vaccines
Table 7. Major Players of Bispecific Antibodies
Table 8. Major Players of Cytokine Therapy
Table 9. Tumor Immune Cell Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Tumor Immune Cell Therapy Market Size by Type (2019-2024) & ($ millions)
Table 11. Global Tumor Immune Cell Therapy Market Size Market Share by Type (2019-2024)
Table 12. Tumor Immune Cell Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 13. Global Tumor Immune Cell Therapy Market Size by Application (2019-2024) & ($ millions)
Table 14. Global Tumor Immune Cell Therapy Market Size Market Share by Application (2019-2024)
Table 15. Global Tumor Immune Cell Therapy Revenue by Player (2019-2024) & ($ millions)
Table 16. Global Tumor Immune Cell Therapy Revenue Market Share by Player (2019-2024)
Table 17. Tumor Immune Cell Therapy Key Players Head office and Products Offered
Table 18. Tumor Immune Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Tumor Immune Cell Therapy Market Size by Region (2019-2024) & ($ millions)
Table 22. Global Tumor Immune Cell Therapy Market Size Market Share by Region (2019-2024)
Table 23. Global Tumor Immune Cell Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 24. Global Tumor Immune Cell Therapy Revenue Market Share by Country/Region (2019-2024)
Table 25. Americas Tumor Immune Cell Therapy Market Size by Country (2019-2024) & ($ millions)
Table 26. Americas Tumor Immune Cell Therapy Market Size Market Share by Country (2019-2024)
Table 27. Americas Tumor Immune Cell Therapy Market Size by Type (2019-2024) & ($ millions)
Table 28. Americas Tumor Immune Cell Therapy Market Size Market Share by Type (2019-2024)
Table 29. Americas Tumor Immune Cell Therapy Market Size by Application (2019-2024) & ($ millions)
Table 30. Americas Tumor Immune Cell Therapy Market Size Market Share by Application (2019-2024)
Table 31. APAC Tumor Immune Cell Therapy Market Size by Region (2019-2024) & ($ millions)
Table 32. APAC Tumor Immune Cell Therapy Market Size Market Share by Region (2019-2024)
Table 33. APAC Tumor Immune Cell Therapy Market Size by Type (2019-2024) & ($ millions)
Table 34. APAC Tumor Immune Cell Therapy Market Size by Application (2019-2024) & ($ millions)
Table 35. Europe Tumor Immune Cell Therapy Market Size by Country (2019-2024) & ($ millions)
Table 36. Europe Tumor Immune Cell Therapy Market Size Market Share by Country (2019-2024)
Table 37. Europe Tumor Immune Cell Therapy Market Size by Type (2019-2024) & ($ millions)
Table 38. Europe Tumor Immune Cell Therapy Market Size by Application (2019-2024) & ($ millions)
Table 39. Middle East & Africa Tumor Immune Cell Therapy Market Size by Region (2019-2024) & ($ millions)
Table 40. Middle East & Africa Tumor Immune Cell Therapy Market Size by Type (2019-2024) & ($ millions)
Table 41. Middle East & Africa Tumor Immune Cell Therapy Market Size by Application (2019-2024) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Tumor Immune Cell Therapy
Table 43. Key Market Challenges & Risks of Tumor Immune Cell Therapy
Table 44. Key Industry Trends of Tumor Immune Cell Therapy
Table 45. Global Tumor Immune Cell Therapy Market Size Forecast by Region (2025-2030) & ($ millions)
Table 46. Global Tumor Immune Cell Therapy Market Size Market Share Forecast by Region (2025-2030)
Table 47. Global Tumor Immune Cell Therapy Market Size Forecast by Type (2025-2030) & ($ millions)
Table 48. Global Tumor Immune Cell Therapy Market Size Forecast by Application (2025-2030) & ($ millions)
Table 49. MEDINET Co Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 50. MEDINET Co Tumor Immune Cell Therapy Product Offered
Table 51. MEDINET Co Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 52. MEDINET Co Main Business
Table 53. MEDINET Co Latest Developments
Table 54. Erytech Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 55. Erytech Tumor Immune Cell Therapy Product Offered
Table 56. Erytech Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Erytech Main Business
Table 58. Erytech Latest Developments
Table 59. Seta Clinic Group Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 60. Seta Clinic Group Tumor Immune Cell Therapy Product Offered
Table 61. Seta Clinic Group Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Seta Clinic Group Main Business
Table 63. Seta Clinic Group Latest Developments
Table 64. Takeda Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 65. Takeda Tumor Immune Cell Therapy Product Offered
Table 66. Takeda Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Takeda Main Business
Table 68. Takeda Latest Developments
Table 69. SBI Holdings Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 70. SBI Holdings Tumor Immune Cell Therapy Product Offered
Table 71. SBI Holdings Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. SBI Holdings Main Business
Table 73. SBI Holdings Latest Developments
Table 74. Oxford BioTherapeutics Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 75. Oxford BioTherapeutics Tumor Immune Cell Therapy Product Offered
Table 76. Oxford BioTherapeutics Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Oxford BioTherapeutics Main Business
Table 78. Oxford BioTherapeutics Latest Developments
Table 79. Fate Therapeutics Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 80. Fate Therapeutics Tumor Immune Cell Therapy Product Offered
Table 81. Fate Therapeutics Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Fate Therapeutics Main Business
Table 83. Fate Therapeutics Latest Developments
Table 84. Gilead Sciences Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 85. Gilead Sciences Tumor Immune Cell Therapy Product Offered
Table 86. Gilead Sciences Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Gilead Sciences Main Business
Table 88. Gilead Sciences Latest Developments
Table 89. Novartis Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 90. Novartis Tumor Immune Cell Therapy Product Offered
Table 91. Novartis Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Novartis Main Business
Table 93. Novartis Latest Developments
Table 94. Osiris Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 95. Osiris Tumor Immune Cell Therapy Product Offered
Table 96. Osiris Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Osiris Main Business
Table 98. Osiris Latest Developments
Table 99. Vericel Corporation Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 100. Vericel Corporation Tumor Immune Cell Therapy Product Offered
Table 101. Vericel Corporation Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Vericel Corporation Main Business
Table 103. Vericel Corporation Latest Developments
Table 104. Fujifilm Cellular Dynamics Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 105. Fujifilm Cellular Dynamics Tumor Immune Cell Therapy Product Offered
Table 106. Fujifilm Cellular Dynamics Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Fujifilm Cellular Dynamics Main Business
Table 108. Fujifilm Cellular Dynamics Latest Developments
Table 109. JCR Pharmaceuticals Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 110. JCR Pharmaceuticals Tumor Immune Cell Therapy Product Offered
Table 111. JCR Pharmaceuticals Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. JCR Pharmaceuticals Main Business
Table 113. JCR Pharmaceuticals Latest Developments
Table 114. Beike Biotechnology Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 115. Beike Biotechnology Tumor Immune Cell Therapy Product Offered
Table 116. Beike Biotechnology Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Beike Biotechnology Main Business
Table 118. Beike Biotechnology Latest Developments
Table 119. Golden Meditech Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 120. Golden Meditech Tumor Immune Cell Therapy Product Offered
Table 121. Golden Meditech Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. Golden Meditech Main Business
Table 123. Golden Meditech Latest Developments
Table 124. Guanhao Biotech Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 125. Guanhao Biotech Tumor Immune Cell Therapy Product Offered
Table 126. Guanhao Biotech Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Guanhao Biotech Main Business
Table 128. Guanhao Biotech Latest Developments
Table 129. Beroni Group Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 130. Beroni Group Tumor Immune Cell Therapy Product Offered
Table 131. Beroni Group Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. Beroni Group Main Business
Table 133. Beroni Group Latest Developments
Table 134. Legend Biotech Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 135. Legend Biotech Tumor Immune Cell Therapy Product Offered
Table 136. Legend Biotech Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 137. Legend Biotech Main Business
Table 138. Legend Biotech Latest Developments
Table 1. Tumor Immune Cell Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Tumor Immune Cell Therapy Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Immune Checkpoint Inhibitors
Table 4. Major Players of Chimeric Antigen Receptor T-cell Therapy
Table 5. Major Players of Tumor-Infiltrating Lymphocytes Therapy
Table 6. Major Players of Cancer Vaccines
Table 7. Major Players of Bispecific Antibodies
Table 8. Major Players of Cytokine Therapy
Table 9. Tumor Immune Cell Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Tumor Immune Cell Therapy Market Size by Type (2019-2024) & ($ millions)
Table 11. Global Tumor Immune Cell Therapy Market Size Market Share by Type (2019-2024)
Table 12. Tumor Immune Cell Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 13. Global Tumor Immune Cell Therapy Market Size by Application (2019-2024) & ($ millions)
Table 14. Global Tumor Immune Cell Therapy Market Size Market Share by Application (2019-2024)
Table 15. Global Tumor Immune Cell Therapy Revenue by Player (2019-2024) & ($ millions)
Table 16. Global Tumor Immune Cell Therapy Revenue Market Share by Player (2019-2024)
Table 17. Tumor Immune Cell Therapy Key Players Head office and Products Offered
Table 18. Tumor Immune Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Tumor Immune Cell Therapy Market Size by Region (2019-2024) & ($ millions)
Table 22. Global Tumor Immune Cell Therapy Market Size Market Share by Region (2019-2024)
Table 23. Global Tumor Immune Cell Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 24. Global Tumor Immune Cell Therapy Revenue Market Share by Country/Region (2019-2024)
Table 25. Americas Tumor Immune Cell Therapy Market Size by Country (2019-2024) & ($ millions)
Table 26. Americas Tumor Immune Cell Therapy Market Size Market Share by Country (2019-2024)
Table 27. Americas Tumor Immune Cell Therapy Market Size by Type (2019-2024) & ($ millions)
Table 28. Americas Tumor Immune Cell Therapy Market Size Market Share by Type (2019-2024)
Table 29. Americas Tumor Immune Cell Therapy Market Size by Application (2019-2024) & ($ millions)
Table 30. Americas Tumor Immune Cell Therapy Market Size Market Share by Application (2019-2024)
Table 31. APAC Tumor Immune Cell Therapy Market Size by Region (2019-2024) & ($ millions)
Table 32. APAC Tumor Immune Cell Therapy Market Size Market Share by Region (2019-2024)
Table 33. APAC Tumor Immune Cell Therapy Market Size by Type (2019-2024) & ($ millions)
Table 34. APAC Tumor Immune Cell Therapy Market Size by Application (2019-2024) & ($ millions)
Table 35. Europe Tumor Immune Cell Therapy Market Size by Country (2019-2024) & ($ millions)
Table 36. Europe Tumor Immune Cell Therapy Market Size Market Share by Country (2019-2024)
Table 37. Europe Tumor Immune Cell Therapy Market Size by Type (2019-2024) & ($ millions)
Table 38. Europe Tumor Immune Cell Therapy Market Size by Application (2019-2024) & ($ millions)
Table 39. Middle East & Africa Tumor Immune Cell Therapy Market Size by Region (2019-2024) & ($ millions)
Table 40. Middle East & Africa Tumor Immune Cell Therapy Market Size by Type (2019-2024) & ($ millions)
Table 41. Middle East & Africa Tumor Immune Cell Therapy Market Size by Application (2019-2024) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Tumor Immune Cell Therapy
Table 43. Key Market Challenges & Risks of Tumor Immune Cell Therapy
Table 44. Key Industry Trends of Tumor Immune Cell Therapy
Table 45. Global Tumor Immune Cell Therapy Market Size Forecast by Region (2025-2030) & ($ millions)
Table 46. Global Tumor Immune Cell Therapy Market Size Market Share Forecast by Region (2025-2030)
Table 47. Global Tumor Immune Cell Therapy Market Size Forecast by Type (2025-2030) & ($ millions)
Table 48. Global Tumor Immune Cell Therapy Market Size Forecast by Application (2025-2030) & ($ millions)
Table 49. MEDINET Co Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 50. MEDINET Co Tumor Immune Cell Therapy Product Offered
Table 51. MEDINET Co Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 52. MEDINET Co Main Business
Table 53. MEDINET Co Latest Developments
Table 54. Erytech Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 55. Erytech Tumor Immune Cell Therapy Product Offered
Table 56. Erytech Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Erytech Main Business
Table 58. Erytech Latest Developments
Table 59. Seta Clinic Group Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 60. Seta Clinic Group Tumor Immune Cell Therapy Product Offered
Table 61. Seta Clinic Group Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Seta Clinic Group Main Business
Table 63. Seta Clinic Group Latest Developments
Table 64. Takeda Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 65. Takeda Tumor Immune Cell Therapy Product Offered
Table 66. Takeda Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Takeda Main Business
Table 68. Takeda Latest Developments
Table 69. SBI Holdings Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 70. SBI Holdings Tumor Immune Cell Therapy Product Offered
Table 71. SBI Holdings Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. SBI Holdings Main Business
Table 73. SBI Holdings Latest Developments
Table 74. Oxford BioTherapeutics Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 75. Oxford BioTherapeutics Tumor Immune Cell Therapy Product Offered
Table 76. Oxford BioTherapeutics Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Oxford BioTherapeutics Main Business
Table 78. Oxford BioTherapeutics Latest Developments
Table 79. Fate Therapeutics Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 80. Fate Therapeutics Tumor Immune Cell Therapy Product Offered
Table 81. Fate Therapeutics Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Fate Therapeutics Main Business
Table 83. Fate Therapeutics Latest Developments
Table 84. Gilead Sciences Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 85. Gilead Sciences Tumor Immune Cell Therapy Product Offered
Table 86. Gilead Sciences Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Gilead Sciences Main Business
Table 88. Gilead Sciences Latest Developments
Table 89. Novartis Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 90. Novartis Tumor Immune Cell Therapy Product Offered
Table 91. Novartis Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Novartis Main Business
Table 93. Novartis Latest Developments
Table 94. Osiris Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 95. Osiris Tumor Immune Cell Therapy Product Offered
Table 96. Osiris Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Osiris Main Business
Table 98. Osiris Latest Developments
Table 99. Vericel Corporation Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 100. Vericel Corporation Tumor Immune Cell Therapy Product Offered
Table 101. Vericel Corporation Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Vericel Corporation Main Business
Table 103. Vericel Corporation Latest Developments
Table 104. Fujifilm Cellular Dynamics Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 105. Fujifilm Cellular Dynamics Tumor Immune Cell Therapy Product Offered
Table 106. Fujifilm Cellular Dynamics Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Fujifilm Cellular Dynamics Main Business
Table 108. Fujifilm Cellular Dynamics Latest Developments
Table 109. JCR Pharmaceuticals Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 110. JCR Pharmaceuticals Tumor Immune Cell Therapy Product Offered
Table 111. JCR Pharmaceuticals Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. JCR Pharmaceuticals Main Business
Table 113. JCR Pharmaceuticals Latest Developments
Table 114. Beike Biotechnology Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 115. Beike Biotechnology Tumor Immune Cell Therapy Product Offered
Table 116. Beike Biotechnology Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Beike Biotechnology Main Business
Table 118. Beike Biotechnology Latest Developments
Table 119. Golden Meditech Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 120. Golden Meditech Tumor Immune Cell Therapy Product Offered
Table 121. Golden Meditech Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. Golden Meditech Main Business
Table 123. Golden Meditech Latest Developments
Table 124. Guanhao Biotech Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 125. Guanhao Biotech Tumor Immune Cell Therapy Product Offered
Table 126. Guanhao Biotech Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Guanhao Biotech Main Business
Table 128. Guanhao Biotech Latest Developments
Table 129. Beroni Group Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 130. Beroni Group Tumor Immune Cell Therapy Product Offered
Table 131. Beroni Group Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. Beroni Group Main Business
Table 133. Beroni Group Latest Developments
Table 134. Legend Biotech Details, Company Type, Tumor Immune Cell Therapy Area Served and Its Competitors
Table 135. Legend Biotech Tumor Immune Cell Therapy Product Offered
Table 136. Legend Biotech Tumor Immune Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 137. Legend Biotech Main Business
Table 138. Legend Biotech Latest Developments
LIST OF FIGURES
Figure 1. Tumor Immune Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tumor Immune Cell Therapy Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Tumor Immune Cell Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Tumor Immune Cell Therapy Sales Market Share by Country/Region (2023)
Figure 8. Tumor Immune Cell Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Tumor Immune Cell Therapy Market Size Market Share by Type in 2023
Figure 10. Tumor Immune Cell Therapy in Hematological Tumors
Figure 11. Global Tumor Immune Cell Therapy Market: Hematological Tumors (2019-2024) & ($ millions)
Figure 12. Tumor Immune Cell Therapy in Solid Tumors
Figure 13. Global Tumor Immune Cell Therapy Market: Solid Tumors (2019-2024) & ($ millions)
Figure 14. Global Tumor Immune Cell Therapy Market Size Market Share by Application in 2023
Figure 15. Global Tumor Immune Cell Therapy Revenue Market Share by Player in 2023
Figure 16. Global Tumor Immune Cell Therapy Market Size Market Share by Region (2019-2024)
Figure 17. Americas Tumor Immune Cell Therapy Market Size 2019-2024 ($ millions)
Figure 18. APAC Tumor Immune Cell Therapy Market Size 2019-2024 ($ millions)
Figure 19. Europe Tumor Immune Cell Therapy Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa Tumor Immune Cell Therapy Market Size 2019-2024 ($ millions)
Figure 21. Americas Tumor Immune Cell Therapy Value Market Share by Country in 2023
Figure 22. United States Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC Tumor Immune Cell Therapy Market Size Market Share by Region in 2023
Figure 27. APAC Tumor Immune Cell Therapy Market Size Market Share by Type (2019-2024)
Figure 28. APAC Tumor Immune Cell Therapy Market Size Market Share by Application (2019-2024)
Figure 29. China Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 33. India Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe Tumor Immune Cell Therapy Market Size Market Share by Country in 2023
Figure 36. Europe Tumor Immune Cell Therapy Market Size Market Share by Type (2019-2024)
Figure 37. Europe Tumor Immune Cell Therapy Market Size Market Share by Application (2019-2024)
Figure 38. Germany Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 39. France Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 40. UK Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa Tumor Immune Cell Therapy Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Tumor Immune Cell Therapy Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Tumor Immune Cell Therapy Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 49. Turkey Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 52. APAC Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 53. Europe Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 55. United States Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 56. Canada Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 57. Mexico Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 58. Brazil Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 59. China Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 60. Japan Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 61. Korea Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 63. India Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 64. Australia Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 65. Germany Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 66. France Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 67. UK Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 68. Italy Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 69. Russia Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 70. Egypt Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 71. South Africa Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 72. Israel Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 73. Turkey Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 75. Global Tumor Immune Cell Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 76. Global Tumor Immune Cell Therapy Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Tumor Immune Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tumor Immune Cell Therapy Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Tumor Immune Cell Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Tumor Immune Cell Therapy Sales Market Share by Country/Region (2023)
Figure 8. Tumor Immune Cell Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Tumor Immune Cell Therapy Market Size Market Share by Type in 2023
Figure 10. Tumor Immune Cell Therapy in Hematological Tumors
Figure 11. Global Tumor Immune Cell Therapy Market: Hematological Tumors (2019-2024) & ($ millions)
Figure 12. Tumor Immune Cell Therapy in Solid Tumors
Figure 13. Global Tumor Immune Cell Therapy Market: Solid Tumors (2019-2024) & ($ millions)
Figure 14. Global Tumor Immune Cell Therapy Market Size Market Share by Application in 2023
Figure 15. Global Tumor Immune Cell Therapy Revenue Market Share by Player in 2023
Figure 16. Global Tumor Immune Cell Therapy Market Size Market Share by Region (2019-2024)
Figure 17. Americas Tumor Immune Cell Therapy Market Size 2019-2024 ($ millions)
Figure 18. APAC Tumor Immune Cell Therapy Market Size 2019-2024 ($ millions)
Figure 19. Europe Tumor Immune Cell Therapy Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa Tumor Immune Cell Therapy Market Size 2019-2024 ($ millions)
Figure 21. Americas Tumor Immune Cell Therapy Value Market Share by Country in 2023
Figure 22. United States Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC Tumor Immune Cell Therapy Market Size Market Share by Region in 2023
Figure 27. APAC Tumor Immune Cell Therapy Market Size Market Share by Type (2019-2024)
Figure 28. APAC Tumor Immune Cell Therapy Market Size Market Share by Application (2019-2024)
Figure 29. China Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 33. India Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe Tumor Immune Cell Therapy Market Size Market Share by Country in 2023
Figure 36. Europe Tumor Immune Cell Therapy Market Size Market Share by Type (2019-2024)
Figure 37. Europe Tumor Immune Cell Therapy Market Size Market Share by Application (2019-2024)
Figure 38. Germany Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 39. France Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 40. UK Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa Tumor Immune Cell Therapy Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Tumor Immune Cell Therapy Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Tumor Immune Cell Therapy Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 49. Turkey Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries Tumor Immune Cell Therapy Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 52. APAC Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 53. Europe Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 55. United States Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 56. Canada Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 57. Mexico Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 58. Brazil Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 59. China Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 60. Japan Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 61. Korea Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 63. India Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 64. Australia Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 65. Germany Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 66. France Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 67. UK Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 68. Italy Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 69. Russia Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 70. Egypt Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 71. South Africa Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 72. Israel Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 73. Turkey Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries Tumor Immune Cell Therapy Market Size 2025-2030 ($ millions)
Figure 75. Global Tumor Immune Cell Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 76. Global Tumor Immune Cell Therapy Market Size Market Share Forecast by Application (2025-2030)
